Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Kei, Sawara"'
Autor:
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, Keisuke Kakisaka, Ippeki Nakaya, Asami Ito, Takuya Watanabe, Kenji Yusa, Tomoaki Nagasawa, Hiroki Sato, Akiko Suzuki, Kei Endo, Yuichi Yoshida, Takayoshi Oikawa, Kei Sawara, Akio Miyasaka, Takayuki Matsumoto
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 4, Pp 701-710 (2024)
Abstract Background and Objective Durvalumab plus tremelimumab (Durva/Treme) has recently been approved as a first-line or later-line treatment for patients with unresectable hepatocellular carcinoma (u-HCC) in Japan. We assessed the real-world outco
Externí odkaz:
https://doaj.org/article/369cfe0c4a6342de957c7f4513f210af
Autor:
Akio Miyasaka, Yuichi Yoshida, Akihiko Murakami, Takao Hoshino, Kei Sawara, Hiroshi Numao, Yasuhiro Takikawa
Publikováno v:
Health Science Reports, Vol 5, Iss 1, Pp n/a-n/a (2022)
Abstract Background and aims To assess the efficacy and safety of treatment with glecaprevir/pibrentasvir in Japanese patients with genotype (GT) 1/2 hepatitis C virus (HCV) infection in a real‐world clinical setting. Methods A total of 230 patient
Externí odkaz:
https://doaj.org/article/963bdacd28ca4915b0021892d1765eb9
Publikováno v:
International Journal of General Medicine
Akio Miyasaka,1,2 Yuichi Yoshida,1,2 Akiko Suzuki,1 Kei Sawara,1,3 Yasuhiro Takikawa1 1Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate, Japan; 2Department of Gastroenterology, Iwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6600b1af41d8901339b2d0312309ee58
https://www.dovepress.com/a-novel-standard-for-hepatocellular-carcinoma-screening-intensity-afte-peer-reviewed-fulltext-article-IJGM
https://www.dovepress.com/a-novel-standard-for-hepatocellular-carcinoma-screening-intensity-afte-peer-reviewed-fulltext-article-IJGM
Autor:
Kei Sawara, Takayoshi Oikawa, Tamami Abe, Yudai Fujiwara, Kei Endo, Hiroki Sato, Hidekatsu Kuorda, Okamoto Takuya, Yasuhiro Takikawa, Miki Yonezawa
Publikováno v:
World Journal of Gastroenterology
Background Lenvatinib is one of the first-line tyrosine kinase inhibitors used for unresectable hepatocellular carcinoma (HCC). In the present study, we evaluated the potential of early changes in the time-intensity curve (TIC) of arterial phase on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7939c0a1c2c6fbbac378187928bedcc1
https://doi.org/10.3748/wjg.v25.i19.2365
https://doi.org/10.3748/wjg.v25.i19.2365
Publikováno v:
Journal of Gastroenterology and Hepatology. 34:1249-1255
BACKGROUND AND AIM L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear. Thus, the cytotoxicity and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b4806dea82de54f21a6683d567d17cf
https://doi.org/10.1111/jgh.14497
https://doi.org/10.1111/jgh.14497
Autor:
Ken Ohuchi, Akihiko Murakami, Kei Sawara, Tadashi Kawakami, Yasuhiro Takikawa, Toshimi Yoshida, Yuichi Yoshida, Daisuke Watanabe, Takao Hoshino, Akio Miyasaka, Koichi Abe
Publikováno v:
Internal Medicine
Objective There are few reports on the outcomes of 12-week paritaprevir, ombitasvir, and ritonavir (PTV/OBV/r) treatment in real-world clinical settings. We aimed to evaluate the efficacy and safety of 12-week treatment with ritonavir-boosted paritap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c7f038fa921099972226158012271a
http://europepmc.org/articles/PMC6207834
http://europepmc.org/articles/PMC6207834
Autor:
Takayoshi Oikawa, Hiroki Sato, Kei Endo, Yudai Fujiwara, Hidekatsu Kuroda, Yohei Kooka, Tamami Abe, Kei Sawara, Tomoaki Nagasawa, Yasuhiro Takikawa
Publikováno v:
Cancers
Volume 13
Issue 6
Cancers, Vol 13, Iss 1295, p 1295 (2021)
Volume 13
Issue 6
Cancers, Vol 13, Iss 1295, p 1295 (2021)
There is limited information regarding the oncological benefits of microwave ablation using ThermosphereTM technology for hepatocellular carcinoma. This study compared the overall survival and recurrence-free survival outcomes among patients with hep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ec5eb485fb7a72b08ceb4a00a8cb93
https://doi.org/10.3390/cancers13061295
https://doi.org/10.3390/cancers13061295
Autor:
Takuro Sato, Jo Kanazawa, Hidekatsu Kuroda, Youhei Kooka, Takayoshi Oikawa, Yasuhiro Takikawa, Kei Endo, Kei Sawara, Tamami Abe, Hiroki Sato, Yudai Fujiwara
Publikováno v:
Cancers
Volume 12
Issue 8
Cancers, Vol 12, Iss 2146, p 2146 (2020)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2146, p 2146 (2020)
Although sarcopenia is characterized by a loss of muscle strength and skeletal muscle mass, few studies have evaluated the effect of muscle strength on hepatocellular carcinoma (HCC) patients. We evaluated the impact of sarcopenia-related factors (gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a4f9dc2f5f17aac7b29a2e7895469d
https://doi.org/10.3390/cancers12082146
https://doi.org/10.3390/cancers12082146
Autor:
Hiroki Sato, Tamami Abe, Yudai Fujiwara, Kei Endo, Takayoshi Oikawa, Yohei Okada, Hidekatsu Kuroda, Yasuhiro Takikawa, Kei Sawara
Publikováno v:
Scandinavian journal of gastroenterology. 53(12)
Transcatheter arterial chemoembolization (TACE) is the standard therapy for patients with intermediate-stage hepatocellular carcinoma (HCC). This study aimed to determine whether combination therapy with radiofrequency ablation (RFA) and TACE was sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91a07b5e6ab075da34b5d2827f5a186d
https://pubmed.ncbi.nlm.nih.gov/30577723
https://pubmed.ncbi.nlm.nih.gov/30577723
Publikováno v:
Hepatology Research. 46:269-276
Aim To examine whether the brain exhibits metabolic disorder prior to overt hepatic encephalopathy in patients with liver cirrhosis (LC), the intracerebral glutamine and myo-inositol levels were determined using 3.0-Tesla (T)1H (proton) magnetic reso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e76db0a7dafc211f8ca5929bb273444
https://doi.org/10.1111/hepr.12519
https://doi.org/10.1111/hepr.12519